Immunosuppressant substitutes in liver transplantation

Affiliations

Comment

N L Ascher. Lancet. 2001.

. 2001 Feb 24;357(9256):571-2.

doi: 10.1016/S0140-6736(00)04073-3.

¹ Department of Surgery, University of California, San Francisco 94143, USA. AscherN@surgery.ucsf.edu

No abstract available

Comment on

Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study.
Schlitt HJ, Barkmann A, Böker KH, Schmidt HH, Emmanouilidis N, Rosenau J, Bahr MJ, Tusch G, Manns MP, Nashan B, Klempnauer J. Schlitt HJ, et al. Lancet. 2001 Feb 24;357(9256):587-91. doi: 10.1016/s0140-6736(00)04055-1. Lancet. 2001. PMID: 11558484 Clinical Trial.
Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease.
Lambert JC, Mann D, Goumidi L, Harris J, Amouyel P, Iwatsubo T, Lendon C, Chartier-Harlin MC. Lambert JC, et al. Lancet. 2001 Feb 24;357(9256):608-9. doi: 10.1016/S0140-6736(00)04063-0. Lancet. 2001. PMID: 11558492